A subsequent new drug (SND) is a modified version of an approved drug, differing in strength, dosage form, route of administration, or indication. It requires regulatory approval based on additional clinical data. SNDs enhance treatment options while ensuring safety, efficacy, and quality compliance per regulatory guidelines.
